Contact
Please use this form to send email to PR contact of this press release:
ROSEN, A TOP RANKED LAW FIRM, Encourages Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation Investors to Secure Counsel Before Important Deadline – IMVT, HSACU, HSAC, HSACW
TO: